(Q58212229)

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Prognostic value of angiogenesis in gastro-intestinal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Thymidine phosphorylase is angiogenic and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Angiogenic factors as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Secretory products of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Role of integrins in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Secretion of epidermal growth factor by macrophages associated with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Suramin, an active drug for prostate cancer: interim observations in a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Angiogenesis: role of calcium-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Targeting gene expression to hypoxic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213

A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2.2.213